Validation of a high-performance chromatographic method for determination of cefotaxime in biological samples

An analytical method for detecting and quantifying cefotaxime in plasma and several tissues is described. The method was developed and validated using plasma and tissues of rats. The samples were analyzed by reversed phase liquid chromatography (HPLC) with UV detection (254 nm). Calibration graphs showed a linear correlation (r > 0.999) over the concentration ranges of 0.5-200 mu g/mL and 1.25-25 mu g/g for plasma and tissues, respectively. The recovery of cefotaxime from plasma standards prepared at the concentrations of 25 mu g/mL and 100 mu g/mL was 98.5 +/- 3.5% and 101.8 +/- 2.2%, respectively. The recovery of cefotaxime from tissue standards of liver, fat and muscle, prepared at the concentration of 10 mu g/g was: 89.8 +/- 1.2% (liver), 103.9 +/- 6.5% (fat) and 97.8 +/- 2.1% (muscle). The detection (LOD) and quantitation (LOQ) limits for plasma samples were established at 0.11 mu g/mL and 0.49 mu g/mL, respectively. The values of these limits for tissues samples were approximately 2.5 times higher: 0.3 mu g/g (LOD) and 1.25 mu g/g (LOQ). For plasma samples, the deviation of the observed concentration from the nominal concentration was less than 5% and the coefficient of variation for within-day and between-day assays was less than 6% and 12%, respectively. The method was used in a pharmacokinetic study of cefotaxime in the rat and the mean values of the pharmacokinetic parameters are given.